প্ৰষ্টেট কেন্সাৰ
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
ক’ত যাব
এই ট্ৰায়েলৰ বাবে ভাৰতৰ 8 খন হস্পিটেলত ৰোগী লোৱা হৈছে।
ৰেজিষ্ট্ৰীৰ সাৰাংশ (কাৰিকৰী)
Researchers are looking for a better way to treat men who have non-metastatic castration-resistant prostate cancer (nmCRPC). This is a type of cancer of the prostate that has not yet spread to other parts of the body and that keeps progressing even when the amount of male sex hormones like testosterone (also called androgens) is reduced to very low levels. To reduce androgen levels in prostate cancer patients, androgen deprivation therapy (ADT) is often used. As androgens stimulate the growth of prostate cancer cells, low levels are needed to reduce or slow the growth of these tumors. In men …
Sponsor: Bayer
ClinicalTrials.gov ত NCT05348876
পঞ্জীত শেষ আপডেট 6 Jul 2026 · আমি পঢ়িছোঁ 20 Oct 2026